The Effect of Branched Chain Amino Acid to the Perioperative Nutritional Status: In Patients with Cirrhosis Undergoing Liver Resection and Patients Awaiting Liver Transplantation.
Not Applicable
Recruiting
- Conditions
- The patient with cirrhosis undergoing liver resection.(hepatocellular carcinoma, bile duct cancer, metastasis of colorectal cancer, and other malignant tumors) The patient awaiting for liver transolantation.(Liver cirrhosis, Hepatocellular carcinoma, Fulminant hepatic failure, Primary billiary cirrosis, Primary screlosing cholangitis, Autoimune hepatitis, and other metabolic liver diseases.)
- Registration Number
- JPRN-UMIN000009154
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have already taken Branched -chain amino acid formula before. 2) Patients who have a past history of milk allergy. 3) Patients who have or be suspected of having glycometabolism dysfunction due to severe diabetes mellitus or bolus administration of steroidal drugs. 4)Patients who are in the first trimester of pregnancy or wish to become pregnant. 5)Patients with amino-acid metabolism dysfunction. 6) Patients with fulminant hepatitis. 7) Patients who are considered medically inappropriate for registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body cell mass
- Secondary Outcome Measures
Name Time Method Infectious complications, Other complications, Neutritional indexes, Length of hospital stay, Recurrence-free survival time, Overall survival time.